Shim Bum Jin, Seo Eun-Min, Hwang Jung-Taek, Kim Do-Young, Yang Jae-Shin, Seo Su-Jung, Hong Myung Sun
Department of Orthopedic Surgery, Chuncheon Sacred Heart Hospital, Hallym University Medical College, Chuncheon, Korea.
Department of Radiology, Chuncheon Sacred Heart Hospital, Hallym University Medical College, Chuncheon, Korea.
Clin Shoulder Elb. 2021 Dec;24(4):231-238. doi: 10.5397/cise.2021.00290. Epub 2021 Nov 26.
Extensor muscle strengthening exercises with counterforce braces (EX) is a conventional conservative treatment for lateral epicondylitis (LE) of the elbow. In addition, polydeoxyribonucleotide (PDRN) or extracorporeal shockwave therapy (ESWT) has been recently used for LE.
Sixty-three patients with chronic LE participated in this study and randomly allocated in three groups (G1: EX, G2: EX+PDRN injection, and G3: EX+ESWT). All of the three groups were taught to perform EX at the first out-patient department (OPD) visit. Group 2 was injected with 3 mL PDRN (5.625 mg/3 mL), while group 3 received ESWT at the first OPD visit. Visual analog scale pain score, Mayo elbow performance score (MEPS), and ultrasonographic examination were checked before, 6 weeks, and 12 weeks after the treatments.
Overall functional scores and ultrasonographic findings in all three groups improved after treatment. The mean MEPS in group 2 improved more than groups 1 and 3 at 6 weeks (G1, 56.9>62.4; G2, 54.3>65.0; G3, 55.7>62.6), and more than group 1 at 12 weeks (G1, 56.9>67.9; G2, 54.3>73.6). The mean common extensor tendon depth (CETD) on ultrasonography in group 2 increased more than groups 1 and 3 at 6 and 12 weeks (6 weeks: G1, 0.385>0.386; G2, 0.332>0.392; G3, 0.334>0.357; 12 weeks: G1, 0.385>0.409; G2, 0.332>0.438; G3, 0.334>0.405 [cm]).
PDRN injections combined with EX exhibited a greater improvement in mean MEPS and mean CETD compared to EX only or EX combined with ESWT for LE within the 12 weeks follow-up.
使用反作用力支具进行伸肌强化锻炼(EX)是治疗肘部外侧上髁炎(LE)的传统保守疗法。此外,聚脱氧核糖核苷酸(PDRN)或体外冲击波疗法(ESWT)最近也被用于治疗LE。
63例慢性LE患者参与本研究,并随机分为三组(G1:EX组;G2:EX+PDRN注射组;G3:EX+ESWT组)。所有三组患者在首次门诊就诊时均接受EX训练指导。第2组在首次门诊就诊时注射3 mL PDRN(5.625 mg/3 mL),而第3组在首次门诊就诊时接受ESWT治疗。在治疗前、治疗后6周和12周检查视觉模拟评分疼痛评分、梅奥肘关节功能评分(MEPS)和超声检查结果。
治疗后所有三组的总体功能评分和超声检查结果均有所改善。第2组的平均MEPS在6周时改善程度大于第1组和第3组(G1,56.9>62.4;G2,54.3>65.0;G3,55.7>62.6),在12周时大于第1组(G1,56.9>67.9;G2,54.3>73.6)。第2组超声检查的平均伸肌总腱深度(CETD)在6周和12周时增加幅度大于第1组和第3组(6周:G1,0.385>0.386;G2,0.332>0.392;G3,0.334>0.357;12周:G1,0.385>0.409;G2,0.332>0.438;G3,0.334>0.405 [cm])。
在12周的随访期内,与单纯EX或EX联合ESWT治疗LE相比,PDRN注射联合EX在平均MEPS和平均CETD方面表现出更大的改善。